NYSE · Medical - Healthcare Information Services

VEEV (VEEV) Stock

$279.23 -2.26% NYSE: VEEV Healthcare

Valuation

MetricValue
Price$279.23
Market Cap$45.36B
P/E Ratio44.56
P/B Ratio6.04
P/S Ratio13.00
EPS (TTM)$5.44
52-Week High$310.50
52-Week Low$148.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE14.00%
ROA11.20%
ROCE13.61%
Gross Margin28.67%
Operating Margin28.67%
Net Margin29.34%
Debt/Equity0.02
Current Ratio4.89

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.9B$2.2B$2.4B$2.7B$3.2B
Operating Profit$505.0M$459.0M$429.0M$691.0M$916.0M
Net Profit$427.0M$488.0M$526.0M$714.0M$909.0M
EPS$2.63$3.00$3.22$4.32$5.44
Op Margin27.3%21.3%18.2%25.2%28.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$3.8B$4.8B$5.9B$7.3B$9.0B
Total Liabilities$905.0M$1.1B$1.3B$1.5B$1.8B
Cash$1.1B$886.0M$703.0M$1.1B$1.4B
Borrowings$55.0M$61.0M$56.0M$76.0M$96.0M

Latest News

Veeva Systems (VEEV) Could Be 41% Undervalued Following Russell Index Removal Simply Wall St. · Jul 10, 2026 Veeva Systems (VEEV) Launches Veeva EHS For Manufacturing And Testing Teams Simply Wall St. · Jul 9, 2026 2 Reasons to Watch VEEV and 1 to Stay Cautious StockStory · Jul 9, 2026 Veeva Systems (VEEV) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · Jul 8, 2026 Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 8, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$764.0M$780.0M$911.0M$1.1B$1.4B
Investing Cash Flow$-360.0M$-1.0B$-1.1B$-721.0M$-1.1B
Financing Cash Flow$-55.0M$-63.0M$-79.0M$-79.0M$-263.0M
Net Cash Flow$410.0M$-252.0M$-183.0M$414.0M$302.0M
Free Cash Flow$750.0M$767.0M$885.0M$1.1B$1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio1.80
EV / EBITDA31.51
FCF Yield3.65%
Quick Ratio5.46
Interest Coverage0.00
Return 1Y1.60%
Return 3Y43.34%
Return 5Y-25.88%

Ownership

Insiders Held8.59%
Institutions Held89.64%
Institutions Float Held98.06%
Institutional HolderSharesReport Date
Blackrock Inc.11,558,8752026-03-31
Vanguard Portfolio Management LLC7,376,0312026-03-31
Vanguard Capital Management LLC6,670,3182026-03-31
Alliancebernstein L.P.6,271,0982026-03-31
Linonia Partnership LP4,924,6262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
A $149.93 -2.36% 30.48 $42.35B 0.66%
ARGXargenx SE $862.93 +0.41% 48.25 $53.99B 0.00%
BDX $187.12 -0.53% 57.29 $51.56B 2.21%
BRKR $56.03 -3.41% 23.24 $8.53B 0.35%
CAH $239.35 +2.02% 32.79 $56.06B 0.86%

About VEEV

VEEV is led by CEO Peter Gassner, employs 7,291 people, headquartered in Pleasanton, US, publicly traded since 2013.

VEEV stock trades at $279.23 with a market capitalization of $45.36B. The stock is valued at a price-to-earnings (P/E) ratio of 44.56, price-to-book of 6.04, price-to-sales of 13.00. Over the past 52 weeks the stock has ranged between $148.05 and $310.50, and currently trades 10.1% below its 52-week high.

On profitability, VEEV generates a return on equity (ROE) of 14.00%, above the typical market average, return on capital employed of 13.61%, an operating margin of 28.67%, a net profit margin of 29.34%.

In its most recent fiscal year, VEEV reported annual revenue of $3.2B, net profit of $909.0M, revenue has compounded at 16.9% a year over the last five years, profit at 19.1% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.02 — a conservative balance sheet with little leverage risk, a current ratio of 4.89, total assets of $9.0B, $1.4B in cash and equivalents.

VEEV has a beta of 0.92.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides